GENELUX ($GNLX) is expected to release its quarterly earnings data on Monday, April 7th before market open, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.19 per share.
You can see Quiver Quantitative's $GNLX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GENELUX Insider Trading Activity
GENELUX insiders have traded $GNLX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $GNLX stock by insiders over the last 6 months:
- THOMAS ZINDRICK (President and CEO) sold 14,315 shares for an estimated $33,497
- JOSEPH CAPPELLO (VP, Pharmaceutical Development) sold 6,300 shares for an estimated $14,742
- JAMES L TYREE sold 3,460 shares for an estimated $8,511
- RALPH SMALLING (Head of Regulatory) sold 2,510 shares for an estimated $5,873
- LOURIE S. ZAK (Chief Financial Officer) sold 2,103 shares for an estimated $4,921
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GENELUX Hedge Fund Activity
We have seen 18 institutional investors add shares of GENELUX stock to their portfolio, and 26 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 214,419 shares (-58.8%) from their portfolio in Q4 2024, for an estimated $506,028
- VANGUARD GROUP INC added 201,967 shares (+20.5%) to their portfolio in Q4 2024, for an estimated $476,642
- RENAISSANCE TECHNOLOGIES LLC removed 107,986 shares (-88.1%) from their portfolio in Q4 2024, for an estimated $254,846
- AFFINITY ASSET ADVISORS, LLC removed 100,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $236,000
- WOODWARD DIVERSIFIED CAPITAL, LLC removed 75,058 shares (-5.6%) from their portfolio in Q4 2024, for an estimated $177,136
- D. E. SHAW & CO., INC. removed 55,012 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $129,828
- MARSHALL WACE, LLP added 52,958 shares (+51.4%) to their portfolio in Q4 2024, for an estimated $124,980
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GENELUX Analyst Ratings
Wall Street analysts have issued reports on $GNLX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 10/28/2024
To track analyst ratings and price targets for GENELUX, check out Quiver Quantitative's $GNLX forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
